Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹929Cr
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

KODYTECH
VS
| Quarter | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | 12.5 |
| 2,951 | 4,206 | 3,226 |
Operating Profit Operating ProfitCr |
| 17.1 | 20.1 | 19.4 |
Other Income Other IncomeCr | 96 | 84 | 94 |
Interest Expense Interest ExpenseCr | 339 | 337 | 343 |
Depreciation DepreciationCr | 305 | 311 | 308 |
| 362 | 569 | 385 |
| 80 | 121 | 81 |
|
Growth YoY PAT Growth YoY% | | | 7.8 |
| 7.9 | 8.5 | 7.6 |
| 2.0 | 3.2 | 2.1 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2025 |
|---|
|
| | 54.8 | 185.2 | |
| 3 | 3 | 6 | 47 |
Operating Profit Operating ProfitCr |
| -1.8 | 17.8 | 41.1 | 34.7 |
Other Income Other IncomeCr | 0 | 0 | 0 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 1 |
| 0 | 1 | 4 | 24 |
| 0 | 0 | 1 | 6 |
|
| | 675.3 | 412.0 | |
| -4.3 | 16.2 | 29.0 | 24.6 |
| -4.0 | 23.1 | 7.1 | 13.8 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 0 | 3 | 13 |
| -2 | -1 | 1 | 42 |
Current Liabilities Current LiabilitiesCr | 1 | 2 | 2 | 33 |
Non Current Liabilities Non Current LiabilitiesCr | 2 | 2 | 7 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 1 | 2 | 7 | 49 |
Non Current Assets Non Current AssetsCr | 0 | 0 | 7 | 63 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | -1 | -8 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | -7 | -35 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 8 | 38 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | -8 | -14 |
| -144.9 | 13.2 | -42.1 | -42.9 |
CFO To EBITDA CFO To EBITDA% | -346.2 | 11.9 | -29.8 | -30.3 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | | | | 1,211 |
Price To Earnings Price To Earnings | | | | 68.7 |
Price To Sales Price To Sales | | | | 16.9 |
Price To Book Price To Book | | | | 22.1 |
| | | | 48.9 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 108.9 |
| -1.8 | 17.8 | 41.1 | 34.7 |
| -4.3 | 16.2 | 29.0 | 24.6 |
| 55.0 | 111.9 | 37.4 | 36.6 |
| 6.3 | -57.0 | 67.8 | 32.2 |
| -9.4 | 26.1 | 21.9 | 15.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Kody Technolab Limited is a high-growth technology enterprise specializing in the convergence of **Artificial Intelligence (AI)**, **Robotics**, and **Software Engineering**. Originally established as a specialized IT services provider, the company has successfully transitioned into a global pioneer of autonomous systems. Kody Technolab focuses on the ground-up engineering of intelligent robotics, connected diagnostic devices, and unified software layers, maintaining a presence in over **30 countries**.
---
### **Proprietary Technology Stack & R&D Philosophy**
The company’s competitive moat is built on a decade of investment in **AI/ML engineering** and **hardware-software integration**. Unlike many competitors who rely on third-party integrations, Kody Technolab follows a "fundamental level" innovation philosophy.
* **In-House AI Models:** Development of proprietary stacks for **Computer Vision**, **Natural Language Processing (NLP)**, and **Time-Series Analytics**.
* **Hardware-Software Synergy:** Deep expertise in embedding **biosensors**, **diagnostic modules**, and **AI inference chips** into field-serviceable robotic units.
* **Independence from "Black Box" Solutions:** By owning the entire architecture, the company protects its long-term cost structures and ensures technical agility, avoiding dependency on external technology providers.
---
### **Robotics Portfolio: Commercial, Industrial, and Security Applications**
The **Kody Robots** division develops specialized autonomous platforms designed for high-footfall commercial environments and critical security infrastructure.
| Product | Primary Function | Key Features & Capabilities |
| :--- | :--- | :--- |
| **Odigo** | Advertising & Navigation | Patented **pDOOH** (programmatic Digital Out-of-Home) platform; facial expression recognition; real-time emotional response adaptation. |
| **Athena** | Surveillance & Security | **360° HD recording**; AI-based threat detection; thermal imaging; autonomous monitoring for law enforcement. |
| **Dasher** | Hospitality Service | Bionic design; autonomous navigation/charging; smart obstacle avoidance for food and beverage delivery. |
| **Vulcan** | Industrial Cleaning | AI-powered floor cleaning for industrial and healthcare settings; automated sanitation processes. |
| **Skanda** | Humanoid Robotics | Designed for high-interaction sectors including **Defense, Logistics, and Healthcare**. |
| **Telos** | Robotic Arm | High-precision collaborative arm for industrial assembly, painting, and packaging. |
---
### **Medigo: Disruptive AI-Driven Healthcare Infrastructure**
A central pillar of the company’s future growth is **Medigo**, an AI-powered health screening platform designed to address the global gap in preventive medicine.
* **Clinical Capability:** Capable of screening for **65+ conditions** with a **95% clinical accuracy threshold**.
* **Efficiency:** Delivers comprehensive reports in **3 minutes** without requiring specialized medical staff on-site.
* **Market Reach:** Targeted at a global underserved population of **500 crore (5 billion) people**.
* **Strategic Deployment:** Aimed at **20 lakh (2 million)** Indian government health centers and **5 lakh+** corporate campuses globally.
* **Public Health Impact:** Enables real-time disease surveillance and epidemic early warning systems for governments, acting as a "fiscal multiplier" by reducing secondary healthcare burdens.
---
### **Global Operations & Strategic Joint Ventures**
Kody Technolab has aggressively expanded its footprint, particularly in the **Middle East (GCC)**, through a sophisticated corporate structure:
* **Kody Middle East Holding L.L.C.-FZ:** A **75% owned subsidiary** based in Dubai acting as the regional anchor.
* **Falcon Tech Robotics LLC:** A **40/60 Joint Venture** with the **Platinum Group** (UAE). This entity focuses on "Made in UAE" manufacturing and exclusive regional distribution.
* **World EMS Private Limited:** The company acquired a significant stake in this entity to manage bulk hardware production, ensuring supply chain control while retaining all **Intellectual Property (IP)**.
* **Kody Media Private Limited:** A **wholly owned subsidiary** focused on commercial robotics applications and media-tech integration.
---
### **Market Traction & Major Deployments**
The company has moved from pilot phases to large-scale commercial contracts with major global entities:
* **Retail & Media:** Agreement to deploy **Odigo** robots across **60 LuLu Group locations** (17 malls and 43 hypermarkets) on an **advertising revenue-sharing basis**. Additional partnerships include **Hypermedia FZ-LLC** and **e& (Etisalat)**.
* **Hospitality:** Procurement orders for **120 Dasher units** via SK Robotics LLP for the Indian hospitality sector.
* **Industrial:** Orders for **Autonomous Mobile Robots (AMR)** from **Sobha Advanced Industries LLC**.
* **Public Safety:** Deployment of **Athena** and **Skanda** at the **Gujarat Police Expo 2024** and the **Tuneland Music Festival**, where they provided security for **35,000+ attendees**.
* **Export Velocity:** Successfully exported **75 Odigo units** within a **60-day** window in early 2025.
---
### **Financial Strategy & Capital Structure**
To support its transition into a global robotics leader, the company has executed several strategic financial moves:
* **Capital Raising:** Approved raising approximately **₹101 crore** in late 2025 (₹35 Cr via equity and ₹66 Cr via convertible warrants) at an issue price of **₹975 per share**.
* **Authorized Capital Expansion:** Increased from **₹6.50 crore** to **₹16.00 crore** over 24 months to facilitate scaling.
* **Shareholder Value:** Executed a **1:1 bonus issue** in November 2024 to improve market liquidity.
* **Revenue Visibility:** Secured a single export order worth **₹70.67 crore** in July 2024 and a **₹25.53 crore** order from its UAE JV in July 2025.
---
### **Risk Factors & Compliance Monitoring**
Investors should note specific regulatory and operational challenges identified in recent periods:
**1. Regulatory & SEBI Compliance:**
* **Preferential Allotment Scrutiny:** As of **February 2026**, the company is under exchange advisory to strengthen internal controls regarding **Regulation 167(6) of SEBI (ICDR) Regulations**. It must prevent intra-day trading by proposed allottees to ensure the successful listing of new shares.
* **Historical Lapses:** Past audits noted **Section 197** violations regarding director remuneration and delays in filing **Form PAS-3**.
**2. Operational Risks:**
* **Human Capital:** The company faces **high attrition levels** and the challenge of maintaining productivity in a remote-work environment.
* **Cyber Security:** Vulnerability to **data theft** and cyber-attacks is a constant threat given the sensitive nature of surveillance and healthcare data.
**3. Macroeconomic Risks:**
* **Geopolitical Volatility:** Conflicts in global regions may impact **service exports** and demand for discretionary tech spending.
* **Technology Obsolescence:** The rapid pace of AI development requires continuous R&D to prevent competitors from deploying superior technologies faster.
| Risk Category | Status / Observation | Impact Level |
| :--- | :--- | :--- |
| **SEBI ICDR Compliance** | Under active exchange advisory (**Feb 2026**) | **High** |
| **Financial Reporting** | Risk of management override/internal control gaps | **Medium** |
| **Statutory Filings** | History of delayed filings (PAS-3) | **Medium** |
| **Market Competition** | Rapid technological shifts in AI/Robotics | **Medium** |